U.S. Tariffs: The Geopolitical Shock Reshaping Global Pharma
Trump’s new tariffs and pricing pressures are redrawing the global pharmaceutical map. Discover what’s at stake for innovation, investments, and Europe’s future in drug development.
What Will Shape Pharma in 2026? Key Innovations and Strategic Moves
The pharmaceutical industry continues to evolve under the pressure of medication affordability, regulatory constraints, and growing environmental expectations. In 2025, drug manufacturers face a major challenge: ensuring laboratories profitability while accelerating innovation and industrial performances. Lactalis Ingredients Pharma, as a committed lactose pharmaceutical manufacturer, closely follows these transformations to better support its partners and customers’ […]
Drug Production in France: 3.5 Billion Medicines and a Resilient Healthcare Ecosystem
Explore the evolution of drug production in France and its impact on the healthcare ecosystem, from CDMOs to government initiatives.
Which Policies to Support Pharmaceutical Innovation?
At a time of challenges that call for change, it is necessary to place health at the heart of public policy.[1] The importance of pharmaceutical innovation cannot be underestimated, in the interests of public health and the economy alike. By responding to medical needs that are poorly covered or not at all,[2] it offers therapeutic […]
European Pharmaceutical Sovereignty: The Role of Local Excipients
Discover how local excipients like pharmaceutical-grade lactose from Lactalis Ingredients Pharma strengthen European pharmaceutical sovereignty by ensuring reliable, high-quality supply chains. Ensuring European Pharmaceutical Sovereignty: The Key Role of Local Excipients The growing need for pharmaceutical sovereignty has become a critical concern for Europe. Recent supply chain disruptions have exposed vulnerabilities in the availability of […]
Navigating the Pharmaceutical Landscape: Exciting Challenges and Innovations for 2025
Each year, the pharmaceutical industry faces new challenges, and 2024 was no exception. From navigating complex regulatory landscapes to integrating cutting-edge technologies, the industry has had to adapt and innovate continuously. In 2024, we witnessed significant advancements in personalized medicine, the rise of telehealth, and the ongoing battle against global health crises. These developments have […]
Pharmaceutical challenges : what to expect in 2024 ?
Pharmaceutical challenges in 2024
How can we respond to the loss of French and European health sovereignty?
Health sovereignty refers to a country’s ability to take charge of the pharmaceutical production chain and ensure the health of its population. The more a country relies on others for its supply of active ingredients, excipients, and production, the less sovereign it becomes. Today, France and Europe are facing the challenges of declining health sovereignty. […]
